Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lilly presents a novel series of selective CB2 agonists

Aug. 22, 2013

Orphan drug status granted to deflazacort

Aug. 21, 2013

FDA grants orphan drug status to dantrolene sodium

Aug. 21, 2013

Eisai files petition in federal court seeking DEA scheduling of Fycompa

Aug. 21, 2013

Varinel synthesizes novel iron chelators for neurodegenerative disorders

Aug. 21, 2013

FDA approves Trokendi XR launch

Aug. 20, 2013

Retrophin to exclusively negotiate development rights for autism and schizophrenia treatment

Aug. 20, 2013

Norgine's Dantrium shown to reduce fatal anesthetic reaction

Aug. 19, 2013

Chelsea Therapeutics submits additional information on Northera NDA

Aug. 19, 2013

Cedars-Sinai begins phase I trial of Copaxone as immunization for Alzheimer's disease

Aug. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...